Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30002974
Basic Information
VIS ID
TVIS30002974
Fusion event
HIV-TNPO2 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr19
Cytoband
p13.13
Reference genome
GRCh37/hg19
Start
12820658/12709844 (Hg38)
End
12820658/12709844 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA19B
Target gene
TNPO2
miRNAs that regulate target gene
hsa-mir-331-3p
;
hsa-mir-186-5p
;
hsa-mir-125a-5p
;
hsa-mir-191-5p
;
hsa-mir-615-3p
;
hsa-mir-598-3p
;
hsa-mir-92b-3p
;
hsa-mir-25-3p
;
hsa-mir-3176
;
hsa-mir-3190-5p
;
hsa-mir-3922-3p
;
hsa-mir-6858-5p
;
hsa-mir-4689
;
hsa-mir-4710
;
hsa-mir-625-5p
;
hsa-mir-6780b-5p
;
hsa-mir-4725-3p
;
hsa-mir-4271
;
hsa-mir-8052
;
hsa-mir-6739-5p
;
hsa-mir-3199
;
hsa-mir-6733-5p
;
hsa-mir-3153
;
hsa-mir-6797-5p
;
hsa-mir-1249-5p
;
hsa-mir-6077
;
hsa-mir-6722-3p
;
hsa-mir-1909-3p
;
hsa-mir-6804-5p
;
hsa-mir-6875-5p
;
hsa-mir-3126-5p
;
hsa-mir-4784
;
hsa-mir-3150b-3p
;
hsa-mir-6886-5p
;
hsa-mir-6798-5p
;
hsa-mir-6794-5p
;
hsa-mir-4716-3p
;
hsa-mir-5584-5p
;
hsa-mir-4779
;
hsa-mir-4318
;
hsa-mir-6873-5p
;
hsa-mir-583
;
hsa-mir-1229-5p
;
hsa-mir-580-3p
;
hsa-mir-6824-5p
;
hsa-mir-3132
;
hsa-mir-197-5p
;
hsa-mir-3175
;
hsa-mir-6878-5p
;
hsa-mir-5703
;
hsa-mir-4516
;
hsa-mir-4434
;
hsa-mir-6770-5p
;
hsa-mir-1253
;
hsa-mir-6776-5p
;
hsa-mir-6861-5p
;
hsa-mir-6742-3p
;
hsa-mir-6791-5p
;
hsa-mir-4292
;
hsa-mir-140-3p
;
hsa-mir-6783-5p
;
hsa-mir-6856-3p
;
hsa-mir-6779-3p
;
hsa-mir-4804-5p
;
hsa-mir-5196-5p
;
hsa-mir-4747-5p
;
hsa-mir-184
;
hsa-mir-605-3p
;
hsa-mir-3910
;
hsa-mir-548s
;
hsa-mir-3926
;
hsa-mir-4328
;
hsa-mir-552-5p
;
hsa-mir-302c-5p
;
hsa-mir-7-2-3p
;
hsa-mir-7-1-3p
;
hsa-mir-5688
;
hsa-mir-495-3p
;
hsa-mir-5582-3p
;
hsa-mir-548f-3p
;
hsa-mir-548e-3p
;
hsa-mir-548az-3p
;
hsa-mir-548ar-3p
;
hsa-mir-548a-3p
;
hsa-mir-6815-3p
;
hsa-mir-135a-5p
;
hsa-mir-135b-5p
;
hsa-mir-6772-3p
;
hsa-mir-6749-3p
;
hsa-mir-4268
;
hsa-mir-4448
;
hsa-mir-4469
;
hsa-mir-6870-3p
;
hsa-mir-6891-3p
;
hsa-mir-6072
;
hsa-mir-1306-5p
;
hsa-mir-19b-3p
;
hsa-mir-19a-3p
;
hsa-mir-224-3p
;
hsa-mir-3165
;
hsa-mir-3616-3p
;
hsa-mir-4459
;
hsa-mir-455-3p
;
hsa-mir-4690-5p
;
hsa-mir-4722-3p
;
hsa-mir-4755-3p
;
hsa-mir-5006-5p
;
hsa-mir-508-5p
;
hsa-mir-5093
;
hsa-mir-522-3p
;
hsa-mir-542-5p
;
hsa-mir-5581-3p
;
hsa-mir-665
;
hsa-mir-6727-3p
;
hsa-mir-6777-5p
;
hsa-mir-6840-3p
;
hsa-mir-6872-3p
;
hsa-mir-6880-5p
;
hsa-mir-6889-5p
;
hsa-mir-8071
;
hsa-mir-874-5p
;
hsa-mir-378j
;
hsa-mir-4782-5p
;
hsa-mir-5706
;
hsa-mir-6839-5p
Nearest miRNA
hsa-mir-10395/Upstream/6180; hsa-let-7e/Downstream/77284;
Nearest TSS
ENST00000633603/Upstream/3170;
ENST00000590633/Downstream/5422;
Nearest CpG islands
None/Target,
chr19-CpG: 112/Upstream/13097
,
chr19-CpG: 129/Downstream/11135
Upstream sequence
agtgctaggattacaggcatgagccaccacacctggccTTTTTAAAAAAttttttgtagaaagagggtttccctatgttgcccaggctggtctcggactc
Downstream sequence
ctgggctaaagcagttgtcctgcttcagcctcctgagtagctgggattacaggcgtgcaccacAGTAACTAGACAAATTTTAGACAAATTTTGAAAGCTT
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate